Common Contracts

83 similar Securities Purchase Agreement contracts by TC BioPharm (Holdings) PLC, Evaxion Biotech a/S, Akari Therapeutics PLC, others

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 21st, 2025 • Ohmyhome LTD • Real estate agents & managers (for others) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 19, 2025, between Ohmyhome Limited, an exempted company incorporated in the Cayman Islands with limited liability (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 14th, 2025 • Mainz Biomed N.V. • Pharmaceutical preparations • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of April [-], 2025, between Mainz Biomed N.V., a public company with limited liability (naamloze vennootschap) under Dutch law (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 24th, 2025 • NuCana PLC • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April [•], 2025, between NuCana plc, a public limited company organized under the laws of the England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 16th, 2025 • Ostin Technology Group Co., Ltd. • Electronic components, nec • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 14, 2025, between Ostin Technology Group Co., Ltd., an exempted company incorporated and registered in the Cayman Islands with limited liability (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 15th, 2025 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 14, 2025, between Can-Fite BioPharma Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 27th, 2025 • Intchains Group LTD • Semiconductors & related devices • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of [ ] (the “Effective Date”), by and between INTCHAINS GROUP LIMITED, a Cayman Islands limited company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 3rd, 2025 • Akari Therapeutics PLC • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 2, 2025 between Akari Therapeutics, Plc, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 12th, 2025 • Innoviz Technologies Ltd. • Motor vehicle parts & accessories • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 10, 2025, between Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 6th, 2025 • Belite Bio, Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this” Agreement”) is dated as of February 5, 2025, between Belite Bio, Inc, a company organized under the law of the Cayman Islands (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 28th, 2025 • Evaxion Biotech a/S • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”), dated as of [·], 2025, is between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 21st, 2025 • ATIF Holdings LTD • Services-management consulting services • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January [*], 2025, between ATIF Holdings Limited, a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 13th, 2025 • Kazia Therapeutics LTD • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”), dated as of January 10, 2025, is between Kazia Therapeutics Limited, a company incorporated under the laws of Australia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

FORM OF SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 26th, 2024 • Quoin Pharmaceuticals, Ltd. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 20, 2024, between Quoin Pharmaceuticals Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 23rd, 2024 • China Liberal Education Holdings LTD • Services-educational services • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 23, 2024, between China Liberal Education Holdings Limited, an exempted company incorporated and registered in the Cayman Islands with limited liability (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 17th, 2024 • Evaxion Biotech a/S • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”), dated as of [·], 2024, is between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 16th, 2024 • SEALSQ Corp • Semiconductors & related devices • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 12, 2024, between SEALSQ Corp., a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 11th, 2024 • Quoin Pharmaceuticals, Ltd. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of __________, 2024, between Quoin Pharmaceuticals Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 9th, 2024 • Mainz Biomed N.V. • Pharmaceutical preparations • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of [_______], 2024, between Mainz Biomed N.V., a public company with limited liability (naamloze vennootschap) under Dutch law (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 15th, 2024 • TMC the Metals Co Inc. • Metal mining • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 14, 2024, between TMC the metals company Inc., a company existing under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 8th, 2024 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of [●], 2024, between IceCure Medical Ltd, a company formed under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 5th, 2024 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of [●], 2024, between IceCure Medical Ltd, a company formed under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 1st, 2024 • Fangdd Network Group Ltd. • Real estate • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 1, 2024, between Fangdd Network Group Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 30th, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 28, 2024, between TC BioPharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006, as amended with company number SC713098 (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 23rd, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of __, 2024, between TC BioPharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006, as amended with company number SC713098 (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 15th, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 13, 2024, between TC BioPharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006, as amended with company number SC713098 (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 9th, 2024 • TC BioPharm (Holdings) PLC • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August __, 2024, between TC BioPharm (Holdings) plc, a public limited company incorporated in Scotland pursuant to the Companies Act 2006, as amended with company number SC713098 (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 9th, 2024 • NaaS Technology Inc. • Retail-retail stores, nec • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 12, 2024, between NaaS Technology Inc., a company organized under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 26th, 2024 • Belite Bio, Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 25, 2024, between Belite Bio, Inc, a Cayman Islands exempted company (the “Company”), and the purchaser identified on the signature page hereto (the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 12th, 2024 • NeuroSense Therapeutics Ltd. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 10, 2024, between NeuroSense Therapeutics Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 1st, 2024 • Vaccinex, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 29, 2024, between Vaccinex, Inc., a Delaware corporation (the “Company”), and Alzheimer’s Drug Discovery Foundation, a Delaware non-profit corporation (the “Purchaser”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 18th, 2024 • SOS LTD • Finance services • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March __, 2024, between SOS Limited., a Cayman Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 13th, 2024 • NaaS Technology Inc. • Retail-retail stores, nec • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 12, 2024, between NaaS Technology Inc., a company organized under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 11th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 11, 2024 between Akari Therapeutics, Plc, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 7th, 2024 • SOS LTD • Finance services • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March __, 2024, between SOS Limited., a Cayman Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 5th, 2024 • Evaxion Biotech a/S • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”), dated as of February 1, 2024, is between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).